Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosisResults from the HERCULES phase 3 ...

Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called ...

Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis Results from the HERCULES phase 3 study showed delay in disability progression in people ...

Tolebrutinib is an oral, brain-penetrant, and bioactive Bruton’s tyrosine kinase inhibitor that modulates peripheral ...

Researchers from the Netherlands Institute for Neuroscience (NIN) have discovered new potential therapeutic targets for ...

A new AI tool, MindGlide, can rapidly analyze routine brain MRI scans to detect subtle changes caused by multiple sclerosis ...

MindGlide is an AI tool from UCL that can help interpret and assess how well treatments are working for people with MS.

Researchers at UCL have developed an innovative AI tool called MindGlide, designed to transform the way MS treatments are ...

The actress boosts awareness of MS as the West Hollywood-based neurologist works to limit its effect on patients ...

Quantum is partnering with Massachusetts General Hospital on a clinical study to test a PET tracer for monitoring response to ...

In the Phase III MUSETTE study, a higher dose of intravenous Ocrevus (ocrelizumab) did not provide additional benefit in ...

The AI tool, called MindGlide, developed by researchers from the University College London (UCL) uses mathematical models to ...